Healthcare and Societal Costs in Patients with COPD and Breathlessness after Completion of a Comprehensive Rehabilitation Program.
COPD
; 18(2): 170-180, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33719787
ABSTRACT
Breathlessness is one of the most frequent symptoms in chronic obstructive pulmonary disease (COPD). COPD may result in disability, decreased productivity and increased healthcare costs. The presence of comorbidities increases healthcare utilization. However, the impact of breathlessness burden on healthcare utilization and daily activities is unclear. This study's goal was to analyze the impact of breathlessness burden on healthcare and societal costs. In this observational single-center study, patients with COPD were followed-up for 24 months after completion of a comprehensive pulmonary rehabilitation program. Every three months participants completed a cost questionnaire, covering healthcare utilization and impact on daily activities. The results were compared between participants with low (modified Medical Research Council (mMRC) grade <2; LBB) and high baseline breathlessness burden (mMRC grade ≥2; HBB). Healthcare costs in year 1 were 7302 (95% confidence interval 6476-8258) for participants with LBB and 10,738 (9141-12,708) for participants with HBB. In year 2, costs were 8830 (7372-10,562) and 14,933 (12,041-18,520), respectively. Main cost drivers were hospitalizations, contact with other healthcare professionals and rehabilitation. Costs outside the healthcare sector in year 1 were 682 (520-900) for participants with LBB and 1520 (1210-1947) for participants with HBB. In year 2, costs were 829 (662-1046) and 1457 (1126-1821) respectively. HBB in patients with COPD is associated with higher healthcare and societal costs, which increases over time. This study highlights the relevance of reducing costs with adequate breathlessness relief. When conventional approaches fail to improve breathlessness, a personalized holistic approach is warranted.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença Pulmonar Obstrutiva Crônica
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
Limite:
Humans
Idioma:
En
Revista:
COPD
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Holanda